Reveragen Biopharma
ReveraGen Biopharma, located in Rockville, MD, is a pioneering company in the field of drug development, particularly known for its innovative approach to steroid chemistry and clinical trial design. The company is recognized for its successful venture philanthropy model, which aims to benefit non-profit organizations through advancements in therapeutic solutions.
The company's groundbreaking therapy, vamorolone, has recently become the first treatment for Duchenne muscular dystrophy (DMD) to receive approvals from both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). This dual approval marks a significant milestone in the treatment landscape for DMD, showcasing ReveraGen's commitment to addressing rare muscular disorders and improving patient outcomes.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

